Answers are grounded in this paper and cite their sources.
Sodium valproate given in doses of 750-3000 mg daily to eight schizophrenic patients produced a qualitatively similar increase in symptoms in five. CSF showed no significant change in gamma-amino-butyric acid or methoxy hydroxyphenyl glycol, but homovanillic acid increased non-significantly in five patients.
No takes yet. Share an insight, caveat, or question.
Lautin et al. (1980) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: